coumarin has been researched along with 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonvini, P; Cozza, G; Gianoncelli, A; Meggio, F; Moro, S; Pasquale, R; Pinna, LA; Rosolen, A; Zagotto, G; Zorzi, E | 1 |
1 other study(ies) available for coumarin and 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one
| Article | Year |
|---|---|
Urolithin as a converging scaffold linking ellagic acid and coumarin analogues: design of potent protein kinase CK2 inhibitors.
Topics: Apoptosis; Binding Sites; Casein Kinase II; Catalytic Domain; Cell Line, Tumor; Coumarins; Crystallography, X-Ray; Drug Design; Ellagic Acid; Humans; Protein Kinase Inhibitors | 2011 |